Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/26032
Title: Global Issues of Radiopharmaceutical Access and Availability: A Nuclear Medicine Global Initiative Project.
Austin Authors: Cutler, Cathy S;Bailey, Elizabeth;Kumar, Vijay;Schwarz, Sally W;Bom, Hee-Seung;Hatazawa, Jun;Paez, Diana;Orellana, Pilar;Louw, Lizette;Mut, Fernando;Kato, Hiroki;Chiti, Arturo;Frangos, Savvas;Fahey, Frederic;Dillehay, Gary;Oh, Seung J;Lee, Dong S;Lee, Sze Ting ;Nunez-Miller, Rodolfo;Bandhopadhyaya, Guru;Pradhan, Prasanta K;Scott, Andrew M 
Affiliation: Brookhaven National Laboratory, Upton, New York
Department of Molecular Imaging and Therapy, Austin Health; University of Melbourne; Olivia Newton-John Cancer Research Institute, and School of Cancer Medicine, La Trobe University, Melbourne, Australia
Department of Nuclear Medicine, Royal North Shore Hospital, Sydney, New South Wales, Australia
Department of Biomedical Sciences, Humanitas University, and Nuclear Medicine Unit, Humanitas Research Hospital-IRCCS, Milan, Italy
University of Melbourne
Excel Diagnostics and Nuclear Oncology Center, Houston, Texas
Nuclear Medicine and Diagnostic Imaging Section, International Atomic Energy Agency, Vienna, Austria
Department of Nuclear Medicine and PET, Westmead Hospital and Children's Hospital at Westmead, and University of Sydney, New South Wales, Australia
Washington University School of Medicine, St Louis, Missouri
Department of Nuclear Medicine, Chonnam National University Hwasun Hospital, Jeollanam, Korea
Department of Quantum Cancer Therapy, Research Center for Nuclear Physics, Osaka University, Osaka, Japan
Nuclear Medicine and Diagnostic Imaging Section, International Atomic Energy Agency, Vienna, Austria
Department of Nuclear Medicine, Charlotte Maxeke Johannesburg Academic Hospital and University of Witwatersrand, Johannesburg, South Africa
Nuclear Medicine Service, Italian Hospital, Montevideo, Uruguay
Department of Nuclear Medicine and Tracer Kinetics, Osaka University Graduate School of Medicine, Osaka, Japan
Department of Nuclear Medicine, Bank of Cyprus Oncology Center, Nicosia, Cyprus
Department of Radiology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts
Department of Radiology, Division of Nuclear Medicine, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois
Department of Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Korea
Department of Nuclear Medicine, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India
Department of Nuclear Medicine, Sanjay Gandhi Post Graduate Institute of Nuclear Medicine, Lucknow, India
School of Cancer Medicine, La Trobe University, Melbourne, Australia
Olivia Newton-John Cancer Research Institute
Molecular Imaging and Therapy
Issue Date: Mar-2021
metadata.dc.date: 2020-07-09
Publication information: Journal of Nuclear Medicine 2021; 62(3): 422-430
Abstract: The Nuclear Medicine Global Initiative was formed in 2012 by 13 international organizations to promote human health by advancing the field of nuclear medicine and molecular imaging by supporting the practice and application of nuclear medicine. The first project focused on standardization of administered activities in pediatric nuclear medicine and resulted in 2 articles. For its second project the Nuclear Medicine Global Initiative chose to explore issues impacting on access and availability of radiopharmaceuticals around the world. Methods: Information was obtained by survey responses from 35 countries on available radioisotopes, radiopharmaceuticals, and kits for diagnostic and therapeutic use. Issues impacting on access and availability of radiopharmaceuticals in individual countries were also identified. Results: Detailed information on radiopharmaceuticals used in each country, and sources of supply, was evaluated. Responses highlighted problems in access, particularly due to the reliance on a sole provider, regulatory issues, and reimbursement, as well as issues of facilities and workforce, particularly in low- and middle-income countries. Conclusion: Strategies to address access and availability of radiopharmaceuticals are outlined, to enable timely and equitable patient access to nuclear medicine procedures worldwide. In the face of disruptions to global supply chains by the coronavirus disease 2019 outbreak, renewed focus on ensuring a reliable supply of radiopharmaceuticals is a major priority for nuclear medicine practice globally.
URI: https://ahro.austin.org.au/austinjspui/handle/1/26032
DOI: 10.2967/jnumed.120.247197
PubMed URL: 32646881
Type: Journal Article
Subjects: access
global issues
radiopharmaceuticals
Appears in Collections:Journal articles

Show full item record

Page view(s)

12
checked on May 15, 2021

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.